CAS
ADMA icon

Coppell Advisory Solutions’s ADMA Biologics ADMA Stock Holding History

Coppell Advisory Solutions’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Buy
1,109
+576
+108% +$9.09K 0.32% 26
2025
Q4 		$308K Sell
533
-295
-36% -$4.97K 0.03% 329
2025
Q3 		$470K Sell
828
-320
-28% -$5.49K 0.05% 258
2025
Q2 		$590K Buy
1,148
+201
+21% +$4.1K 0.07% 216
2025
Q1 		$455K Buy
947
+351
+59% +$6.07K 0.06% 222
2024
Q4 		$314K Sell
596
-242
-29% -$4.55K 0.04% 210
2024
Q3 		$414K Sell
838
-950
-53% -$14.8K 0.06% 186
2024
Q2 		$20K Buy
+1,788
New +$15K ﹤0.01% 783
2023
Q3 		– Sell
-365
Closed -$142K – 1204
2023
Q2 		$142K Buy
+365
New +$1.35K 0.04% 225

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return